11:19 AM EDT, 07/16/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.22% to 1,450.44 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and medical device maker EDAP TMS ( EDAP ) , which rose 7.6% and 3.3% respectively. They were followed by telecommunications company Ericsson (ERIC) and biopharmaceutical company argenx (ARGX), which were up 2.7% and 2.6% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Grifols ( GRFS ) , which fell 3.3% and 2.7% respectively. They were followed by oil and gas company Eni (E) and telecommunications operator Nokia ( NOK ) , which were down 2.1% and 2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Amarin ( AMRN ) , which climbed 6.6% and 2.9% respectively. They were followed by cruise line operator Carnival (CUK) and construction materials supplier CRH (CRH), which increased 2.8% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and NuCana ( NCNA ) , which dropped 3.1% and 2.9% respectively. They were followed by mining company BHP Group ( BHP ) and biopharmaceutical company Verona Pharma ( VRNA ) , which lost 2.5% and 1.2% respectively.